Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice | |
Pan, Xiaoli ; Gong, Neng ; Zhao, Jing ; Yu, Zhe ; Gu, Fenghua ; Chen, Jia ; Sun, Xiaojing ; Zhao, Lei ; Yu, Meijing ; Xu, Zhiru ; Dong, Wenxin ; Qin, Yan ; Fei, Guoqiang ; Zhong, Chunjiu ; Xu, Tian-Le(徐天乐) | |
刊名 | BRAIN |
2010 | |
卷号 | 133期号:pt 5页码:1342-1351 |
关键词 | Alzheimer benfotiamine thiamine glycogen synthase kinase-3 POSITRON-EMISSION-TOMOGRAPHY ALZHEIMERS-DISEASE THIAMINE-DEFICIENCY HYPERGLYCEMIC DAMAGE OXIDATIVE STRESS PHOSPHATE-ESTERS PROTEIN BRAIN RISK DERIVATIVES |
ISSN号 | 0006-8950 |
通讯作者 | Zhong, CJ (reprint author), Zhongshan Hosp, Dept Neurol, Shanghai 200032, Peoples R China,zhongcj@163.com |
英文摘要 | Reduction of glucose metabolism in brain is one of the main features of Alzheimer's disease. Thiamine (vitamin B1)-dependent processes are critical in glucose metabolism and have been found to be impaired in brains from patients with Alzheimer's disease. However, thiamine treatment exerts little beneficial effect in these patients. Here, we tested the effect of benfotiamine, a thiamine derivative with better bioavailability than thiamine, on cognitive impairment and pathology alterations in a mouse model of Alzheimer's disease, the amyloid precursor protein/presenilin-1 transgenic mouse. We show that after a chronic 8 week treatment, benfotiamine dose-dependently enhanced the spatial memory of amyloid precursor protein/presenilin-1 mice in the Morris water maze test. Furthermore, benfotiamine effectively reduced both amyloid plaque numbers and phosphorylated tau levels in cortical areas of the transgenic mice brains. Unexpectedly, these effects were not mimicked by another lipophilic thiamine derivative, fursultiamine, although both benfotiamine and fursultiamine were effective in increasing the levels of free thiamine in the brain. Most notably, benfotiamine, but not fursultiamine, significantly elevated the phosphorylation level of glycogen synthase kinase-3 alpha and -3 beta, and reduced their enzymatic activities in the amyloid precursor protein/presenilin-1 transgenic brain. Therefore, in the animal Alzheimer's disease model, benfotiamine appears to improve the cognitive function and reduce amyloid deposition via thiamine-independent mechanisms, which are likely to include the suppression of glycogen synthase kinase-3 activities. These results suggest that, unlike many other thiamine-related drugs, benfotiamine may be beneficial for clinical Alzheimer's disease treatment. |
学科主题 | Neurosciences & Neurology |
收录类别 | SCI |
资助信息 | Science and Technology Commission of Shanghai Municipality[07DJ14005, 09DZ1950400, 09XD1404900]; National Natural Science Foundation of China[30830035]; State Scientific & Technological Ministry of China[2009ZX09301-011]; Institutes of Brain Science of Fudan University; State Key Laboratory of Neuroscience |
语种 | 英语 |
公开日期 | 2012-07-13 |
内容类型 | 期刊论文 |
源URL | [http://ir.sibs.ac.cn/handle/331001/1595] |
专题 | 上海神经科学研究所_神经所(总) |
推荐引用方式 GB/T 7714 | Pan, Xiaoli,Gong, Neng,Zhao, Jing,et al. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice[J]. BRAIN,2010,133(pt 5):1342-1351. |
APA | Pan, Xiaoli.,Gong, Neng.,Zhao, Jing.,Yu, Zhe.,Gu, Fenghua.,...&Xu, Tian-Le.(2010).Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.BRAIN,133(pt 5),1342-1351. |
MLA | Pan, Xiaoli,et al."Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice".BRAIN 133.pt 5(2010):1342-1351. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论